Agoraphobia

01/01/1999 - "A previous study with agoraphobia/panic patients found that the BZ alprazolam impaired memory during an 8-week treatment and residual impairments were still manifest several weeks after drug withdrawal (Curran et al. 1994). "
01/01/1999 - "Long-term effects of alprazolam on memory: a 3.5 year follow-up of agoraphobia/panic patients."
10/01/1991 - "House calls and alprazolam for agoraphobia."
01/01/1988 - "Fading of therapeutic effects of alprazolam in agoraphobia. "
01/01/1987 - "A double blind study of alprazolam and placebo in 118 patients with agoraphobia and panic is presented. "

08/01/1992 - "The results support the hypothesis that successful imipramine maintenance treatment of patients with panic and agoraphobia can have protective effects against relapse, at least in the first 6 months after the maintenance treatment period."
06/01/1988 - "This study was designed to see whether the high vs low serum level of imipramine influenced the outcome of in vivo exposure therapy on patients with agoraphobia. "
06/01/1987 - "The greater dose effect observed in the low depressed group and the greater response rates found among high-dose patients with low initial depression strongly suggest that the beneficial effect of imipramine in agoraphobia was not primarily antidepressant in nature."
06/01/1987 - "Initial depression and response to imipramine in agoraphobia."
05/01/1987 - "Imipramine treatment of agoraphobia."

11/01/2011 - "Twenty chronically benzodiazepine-medicated and 20 benzodiazepine-free patients with PD with agoraphobia were compared with a group of 20 normal control participants, group-matched for age, education, and gender on a battery of neuropsychological tests assessing short-term, episodic long-term, and semantic memory, as well as visuoconstructive abilities. "
07/01/2007 - "The association between pre- and post-treatment use of SSRIs, benzodiazepines (BZs), and any anti-anxiety or anti-depressant (A/D) medication were investigated for three indicators of treatment outcome (PD severity, presence of agoraphobia (AG), anxiety sensitivity) at post-treatment and 6-month follow-up. "
06/01/2006 - "Patients were not excluded based on the presence of agoraphobia, diagnostic comorbidity, concurrent use of PRN benzodiazepine medications, or previous nonresponse to psychotherapy for PD. "
07/01/1994 - "Indications for benzodiazepines include acute stress reactions, episodic anxiety, fluctuations in generalised anxiety, and as initial treatment for severe panic and agoraphobia. "
06/01/1997 - "The strongest support for combined treatment is for the addition of cognitive behavior therapy to pharmacotherapy for patients with agoraphobia and for those whose benzodiazepine treatment is being discontinued. "

05/01/1988 - "The efficacy of clomipramine hydrochloride in the treatment of agoraphobia was investigated in an eight-week placebo-controlled double-blind study. "
02/01/1989 - "Seventeen outpatients with panic anxiety and agoraphobia were treated with a low, flexible dose of clomipramine in an 8-week open trial. "
12/01/1993 - "The authors examined the effects of clomipramine on agoraphobia in patients who failed to respond to exposure-based behavioral treatment. "
07/01/1990 - "A case is presented of a patient with severe panic disorder and agoraphobia in whom initial treatment with clomipramine resulted in complete elimination of panic attacks, with no improvement in agoraphobic avoidance. "
09/01/2002 - "This study investigated the chronic use (6.3 +/- 0.5 years; mean +/- SEM) of therapeutic doses of clomipramine (57.0 +/- 8.0 mg/day) by outpatients with panic disorder/agoraphobia who were currently in remission to assess impairment of memory and psychomotor functions. "

01/01/1988 - "Monoamine oxidase inhibitors (MAOI's) have been shown to be significantly superior to placebo in the treatment of some anxiety disorders, particularly agoraphobia and mixed anxiety--depressive states. "
01/01/1990 - "In addition to being effective in depressive disorders, monoamine oxidase inhibitors (MAOIs) have been shown to be effective in controlled studies of patient with panic disorder with agoraphobia, social phobia, atypical depression or mixed anxiety and depression, bulimia, posttraumatic stress disorder (PTSD) and borderline personality disorder. "
12/01/1982 - "Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia."
03/01/1985 - "This article reviews the evidence on the efficacy of monoamine oxidase inhibitors (MAOIs) and of alprazolam in the treatment of panic disorder and agoraphobia. "
12/01/1982 - "The efficacy of tricyclic antidepressants and monoamine oxidase inhibitors for the treatment of agoraphobia and other panic disorders is reviewed with an emphasis on controlled prospective studies. "

12/01/1993 - "Both behavior-modification methods and antidepressants have proved to be effective in the treatment of agoraphobia. "
10/01/2010 - "A group of 47 patients with lifetime comorbid BD (n = 35, 74.5%) or otherwise resistant to antidepressants (n = 12, 25.6%), from a population of 326 consecutive outpatients with PD-Agoraphobia evaluated and treated at the Psychiatric Institute of the University of Pisa from 1991 to 1995, and followed for a period of 3 years. "
11/01/1988 - "Antidepressants have a broad-spectrum rather than specific anti-agoraphobia/panic or anti-obsessive-compulsive action. "
11/01/1988 - "In the short term, both antidepressants and exposure therapy usually improve agoraphobia/panic (AP) and obsessive-compulsive (OC) disorders and are accepted by most patients; psychological methods omitting exposure are not consistently helpful. "
10/08/1986 - "[Antidepressive agents in the treatment of agoraphobia and panic--an evaluative review]."

07/01/2015 - "This study compares the differential efficacy of three groups of treatments for agoraphobia: paroxetine combined with cognitive-behavioral therapy, paroxetine combined with cognitive-behavioral therapy and virtual reality exposure, and a group with only paroxetine. "
08/01/1997 - "As shown in 3 short term placebo-controlled trials in patients with panic disorder with or without agoraphobia, oral paroxetine 10 to 60 mg/day is significantly more effective than placebo for most variables measuring reduction in panic attack frequency. "
08/01/1997 - " Oral paroxetine 10 to 60 mg/day is significantly more effective than placebo in reducing the frequency of panic attacks and improving associated symptoms, as shown in short term trials in patients with panic disorder with or without agoraphobia. "
01/01/2004 - "Paroxetine CR also demonstrated efficacy in three well designed studies in patients with panic disorder with or without agoraphobia. "
02/01/2012 - "This study aims to evaluate the differential predictive values of age, age of onset and duration of illness on paroxetine and cognitive-behavioural therapy (CBT) outcome in late-life panic disorder with agoraphobia. "

03/01/1989 - "Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants."
08/01/1988 - "The treatment of patients with panic disorder and agoraphobia with tricyclic antidepressants."
12/01/1982 - "Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia."
12/01/1982 - "The efficacy of tricyclic antidepressants and monoamine oxidase inhibitors for the treatment of agoraphobia and other panic disorders is reviewed with an emphasis on controlled prospective studies. "
01/01/2011 - "A group of 50 patients with a diagnosis of panic disorder with agoraphobia was randomized into two groups to receive: a) cognitive-behavioral therapy with medication; or b) medication (tricyclic antidepressants or selective serotonin reuptake inhibitors). "

12/01/1976 - "Propranolol was effective in treating acute pathological panic, but modest doses of the drug administered for brief periods of time did not alleviate chronic panic attacks associated with agoraphobia. "
12/01/1991 - "We studied the efficacy of propranolol (Inderal) compared to alprazolam (Xanax) in 29 patients with a diagnosis of agoraphobia with panic disorder or panic disorder with or without limited phobic avoidance in a 6-week double-blind controlled experiment. "
02/01/1989 - "The results generally support the efficacy of alprazolam, but not propranolol, in the treatment of panic disorder and agoraphobia with panic attacks. "
02/01/1991 - "Fifty-five young adult patients completed a study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. "
02/01/1989 - "Fifty-five patients completed a 5-week double-blind study comparing alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. "

01/01/1993 - "Fifty-six males and females with panic disorder with or without agoraphobia participated in a 12-week, placebo-controlled treatment study of the efficacy of desipramine (DMI). "
08/01/1987 - "Desipramine in agoraphobia with panic attacks: an open, fixed-dose study."
08/01/1987 - "Fourteen patients who met DSM-III criteria for agoraphobia with panic attacks received 200 mg desipramine (DMI) per day for 12 to 16 weeks on an open basis. "
02/01/1984 - "The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia."
01/01/1984 - "The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia."

08/01/2008 - "Long term studies on treatments combining pharmacotherapy and CBT for PD with or without agoraphobia have found little benefit, however, for combination therapies versus monotherapies. "
08/01/2008 - "The present article reviews the current status of pharmacotherapy for PD with or without agoraphobia as well as the current status of treatments combing pharmacotherapy with cognitive behavior therapy (CBT). "
01/01/1993 - "Combined behavioral therapy and pharmacotherapy of agoraphobia."
05/01/1992 - "Panic and agoraphobia's sequence of improvement during pharmacotherapy."
04/01/1988 - "Drug therapy for agoraphobia."

10/01/1987 - "Five years after treatment in a controlled trial, in which all had received self-exposure homework, a group of 40 agoraphobic outpatients retained marked improvement in agoraphobia, mood, and free-floating anxiety. "
03/01/1996 - "Whereas 94% of the low agoraphobia Ss were free of panic after treatment, only 52% of the high agoraphobia Ss became panic-free. "
01/01/1990 - "This article presents the Agoraphobia Scale (AS), and evidence for its reliability, validity, and sensitivity to change after treatment. "
11/01/1980 - "The assessor's ratings suggested that there had been little change in the patients' agoraphobia since six months after treatment. "
04/01/1979 - "Agoraphobia: a follow-up study four years after treatment."

01/01/1991 - "The introduction of hypnosis provided this young woman with long term relief from her symptoms of agoraphobia and panic. "
04/01/1997 - "A study of exposure in vivo with or without hypnosis in the treatment of panic disorder with agoraphobia."

09/01/2010 - "The tentative conclusion drawn from these results is that pure bibliotherapy with a clear deadline can be effective for people suffering from panic disorder with or without agoraphobia."
12/01/2006 - "This study evaluated a 10-week Internet-based bibliotherapy self-help program with short weekly telephone calls for people suffering from panic disorder with or without agoraphobia. "

08/01/2007 - "The aim of this study was to address claims that among bona fide treatments no one is more efficacious than another by comparing the relative efficacy of cognitive therapy (CT) and relaxation therapy (RT) in the treatment of generalized anxiety disorder (GAD) and panic disorder without agoraphobia (PD). "